Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

23.39 +0.66 (+2.90%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Kenvue Inc. Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
A Closer Look at Kenvue's Options Market Dynamics
Via Benzinga
Spotlight on Kenvue: Analyzing the Surge in Options Activity
Via Benzinga
3 Cheap Dividend Stocks for December 2023
All three of these dividend stocks are trading at great valuations. 
Via The Motley Fool
Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections
UBS has upgraded Johnson & Johnson (NYSE: JNJ), citing a bullish view of the company's pharmaceutical business and expectations for MedTech growth that align with the market, which is... 
Via Benzinga
Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio
Faced with a possible negative outcome in the market, these top healthcare stocks should offer the confidence you need. 
Via InvestorPlace
Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF
There have not been many successful IPOs in 2023, so finding stock picks from the Renaissance IPO ETF won’t be easy. 
Via InvestorPlace
Topics ETFs Initial Public Offering
Exposures Securities Market
Looking Into Kenvue's Recent Short Interest
Via Benzinga
Dividend Kings In Focus: Kenvue
Kenvue operates in the healthcare sector as a consumer products manufacturer. 
Via Talk Markets
Kenvue's Options Frenzy: What You Need to Know
Via Benzinga
CLASS ACTION LAWSUIT FILED AGAINST KENVUE INC. (NYSE: KVUE)
--News Direct-- 
Via News Direct
Topics Lawsuit
Exposures Financial Legal
Class Action Lawsuit Filed Against Kenvue Inc. (NYSE: KVUE)
Kenvue Inc. (NYSE: KVUE) is down over 25% from its debut earlier this year in May 2023. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
A Closer Look at Kenvue's Options Market Dynamics
Via Benzinga
Top 5 Stocks the Smart Money Is Buying
Top hedge funds and investment firms have been buying these stocks. 
Via The Motley Fool
Dividend Aristocrats In Focus: Kenvue
An analysis of Kenvue’s business model, future growth catalysts, and expected returns. 
Via Talk Markets
Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration
Hedge fund portfolios are intensifying their focus on technology stocks, with holdings in mega-cap tech reaching record levels. 
Via Benzinga
Analyst Expectations for Kenvue's Future
Via Benzinga
7 High-Yield Blue Chips Suitable for Any Retiree
Here are seven high-yield blue-chip stocks to help you meet your retirement goals no matter where you are on your investment journey. 
Via InvestorPlace
Topics Retirement
Exposures Pension
Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks
Piper Sandler analyst Korinne Wolfmeyer initiated coverage on several personal care stocks, noting that amid the present economic conditions, consumers are becoming more discerning in their spending. 
Via Benzinga
3 Must-Buy Stocks on Every Market Dip
Be smart and continue buying shares in these securities anytime the market dips and experiences a downturn. 
Via InvestorPlace
3 Strong-Buy Dividend Stocks That Analysts Love
It's important to invest in the market that is – and right now that means looking for strong buy dividend stocks with potentially good upside. 
Via InvestorPlace
Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B
Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over... 
Via Benzinga
Looking At Kenvue's Recent Unusual Options Activity
Via Benzinga
How Is The Market Feeling About Kenvue?
Via Benzinga
Looking At Kenvue's Recent Unusual Options Activity
Via Benzinga
It’s Time to Buy These 3 Dividend Aristocrats Trading Near 52-Week Lows
Investing in Dividend Aristocrats is a good idea. Buying them when they’re near a 52-week low is even better. 
Via InvestorPlace
2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade
Taking advantage of the discounted prices these stocks have been trading at could do wonders for your passive income stream. 
Via The Motley Fool
2 Monster Stocks to Buy Without Any Hesitation
Down 33% and 44%, these two stocks look too good to pass up today. 
Via The Motley Fool
The 3 Best Forever Stocks to Buy in November
While the idea of acquiring “forever stocks” is risky due to the timeframe, these companies benefit from permanent relevance. 
Via InvestorPlace
EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'
A new ETF offers investors exposure to companies with long streaks of raising their dividends. 
Via Benzinga
Topics ETFs
Looking At Kenvue's Recent Unusual Options Activity
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.